Nathaniel R. Mendell

When Your Life Sciences Are on the Line: Protecting Your Company’s Most Valuable Asset: Trade Secrets

DOJ Releases 2024 COVID-19 Fraud Enforcement Task Force Report

True Facts About False Claims: MoFo's FCA Newsletter (April 2024)

Electric Vehicle Risks: New Focus of Regulators

Artificial Intelligence in Healthcare: New Avenues for Liability

DOJ Releases False Claims Act Statistics for Fiscal Year 2023

Ten from MoFo Named to Law360 Editorial Advisory Boards

DOJ’s Healthcare Probes of AI Tools Rooted in Purdue Pharma Case

Outing Companies That Avoid Charges a Dilemma for US Prosecutors

Eleven from MoFo Named to Law360 Editorial Advisory Boards

How to Ensure Effective Threat Intelligence

Law360’s 2023 Massachusetts Editorial Advisory Board

Join MoFo for a CLE Webinar on the Enforcement Risks of Emerging Technologies in Electric Vehicles

The Complexities of AI in Health Care

Legal and Business Issues at the Intersection of Life Sciences and Artificial Intelligence

Galia Amram, Carrie H. Cohen, Bonnie Lau, Haima Marlier, and Nate Mendell to Present “Investigations and Enforcement Update” to Aledade

Life Sciences MoForum 2024 - The State of the Life Sciences

Join MoFo for a Life Sciences CLE Webinar on AKS/FCA Enforcement Trends

When Your Life Sciences Are on the Line: FTC’s Final Noncompete Rule

When Your Life Sciences Are on the Line: Privacy and Security Enforcement Trends

When Your Life Sciences Are on the Line: Protecting Your Company’s Most Valuable Asset: Trade Secrets

Above Board: The U.S. DOJ’s New Corporate Voluntary Self-Disclosure Policy